Patchy hair loss? It may be alopecia areata.
The Rezolve AA research study is enrolling volunteers with alopecia areata now!
Are you experiencing hair loss due to alopecia areata – a condition where hair loss results from the immune system attacking the hair follicle? We are recruiting eligible participants for a new study investigating rezpegaldesleukin (also known as REZPEG), a targeted therapy that may help reverse hair loss in patients with alopecia areata (AA).
Study benefits include:
- Reimbursement for time and travel may be available.
- There will be no cost to you for taking part in this study, and you will be provided with all study medication, examinations, and medical care related to the study.
To Participate in this research study, volunteers must:
- If male, be ages 18-60
- If female, be ages 18-70
- Have hair loss from alopecia areata affecting more than 50% of the scalp
- Be experiencing an episode that has lasted less than 8 years
- Have a stable amount of hair loss over the last 6 months
- Be available to attend 24 visits at the clinic over 65 weeks. A 16 week extension may also be available for eligible participants.
Study Site Location
Need help? Have questions?
Contact Us
Call or text: (805) 705-5872
Email: contact@clinicallymedia.com
